Stage-Associated MicroRNA Expression Patterns in Human Great Saphenous Veins across Chronic Venous Disease Severity
Journal of Vascular Research · 12.06.2026 · 1-10
DOI: 10.1159/000553000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Research, online erschienen am 12.06.2026. Verfasst von Leonardo Oliveira Pimentel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Orthopedics, School of Medicine, Sao Paulo State University - UNESP, Botucatu, Brazil. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Introduction
Chronic venous disease (CVD) is characterized by progressive venous wall remodeling, extracellular matrix dysregulation, and chronic inflammation. MicroRNAs (miRNAs) regulate vascular processes, but their expression in human venous tissue across disease stages remains incompletely defined. We evaluated global miRNA expression in great saphenous veins across CVD severity.
Methods
In this cross-sectional pilot study, paraffin-embedded vein samples were obtained from patients with CVD and classified according to CEAP criteria into early-stage (C2–C3; G1) and advanced-stage (C4–C5; G2). Vein segments from patients without venous reflux undergoing arterial revascularization served as controls. Global miRNA expression profiling was performed using the GeneChip® miRNA 4.0 Array with multiple-testing correction. Direct statistical comparison between G1 and G2 was not performed.
Results
Twenty-seven samples were analyzed (6 controls, 12 G1, 9 G2). A total of 155 miRNAs were significantly dysregulated in CVD compared with controls. Most miRNAs were detected in both G1 and G2 comparisons, whereas 36 were identified only in the G1 vs. control comparison and two (hsa-miR-7977 and hsa-miR-23a-5p) only in the G2 vs. control comparison. Conclusion: miRNA profiling suggests stage-associated expression patterns in human saphenous veins, indicating early molecular remodeling during CVD progression. These findings are exploratory and require independent validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Orthopedics, School of Medicine, Sao Paulo State University - UNESP, Botucatu, Brazil.
- Department of Surgery and Orthopedics, School of Medicine, Sao Paulo State University - UNESP, Botucatu, Brazil, matheusbertanha@gmail.com.
- VascPath Laboratory, Bern, Switzerland.
- Experimental Research Unity (UNIPEX), School of Medicine, São Paulo State University (UNESP), Botucatu, Brazil.
- School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Botucatu, Brazil.
- Laboratory of Molecular Biology Toribio Rodriguez de Mendoza, Medical School, Faculty of Health Sciences and Institute of Livestock and Biotechnology, Amazonas National University (UNTRM-A), Chachapoyas, Peru.
Zitieren
APA
Pimentel, L. O., Rezk, E. A. S., Bertanha, M., Yoshida, R. A., Janzen, J., Felix, T. F., de Carvalho, M., Lapa, R. M. L., Rodrigues, L. S., Reis, P. P., Minutentag, I. W., & Yoshida, W. B. (2026). Stage-Associated MicroRNA Expression Patterns in Human Great Saphenous Veins across Chronic Venous Disease Severity. Journal of Vascular Research, 1-10. https://doi.org/10.1159/000553000
Vancouver
Pimentel LO, Rezk EAS, Bertanha M, Yoshida RA, Janzen J, Felix TF, et al. Stage-Associated MicroRNA Expression Patterns in Human Great Saphenous Veins across Chronic Venous Disease Severity. Journal of Vascular Research. 2026:1-10. doi:10.1159/000553000
BibTeX
@article{Pimentel2026,
author = {Pimentel, Leonardo Oliveira and Rezk, Eduardo Abrão Spinola and Bertanha, Matheus and Yoshida, Ricardo de Alvarenga and Janzen, Jan and Felix, Tainara Francine and de Carvalho, Márcio and Lapa, Rainer M Lopez and Rodrigues, Lenize Silva and Reis, Patricia Pintor and Minutentag, Iael Weissberg and Yoshida, Winston Bonetti},
title = {Stage-Associated MicroRNA Expression Patterns in Human Great Saphenous Veins across Chronic Venous Disease Severity},
journal = {Journal of Vascular Research},
year = {2026},
pages = {1--10},
doi = {10.1159/000553000}
}
EUVIMED